Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2014 Sep;52(9):3504-5.
doi: 10.1128/JCM.01731-14.

Reply to "molecular diagnosis of rifampin-monoresistant tuberculosis in Indian patients: problems with a discordance analysis"

Sarman Singh  1 , Syed Beenish Rufai  2 , Parveen Kumar  2 , Jitendra Singh  2
Affiliations
Comment

Reply to "molecular diagnosis of rifampin-monoresistant tuberculosis in Indian patients: problems with a discordance analysis"

Sarman Singh et al. J Clin Microbiol. 2014 Sep.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Alland D, Michael JS, Denkinger CM, Cirillo DM. 2014. Molecular diagnosis of rifampin-monoresistant tuberculosis in Indian patients: problems with a discordance analysis. J. Clin. Microbiol. 52:3503. 10.1128/JCM.01607-14. - DOI - PMC - PubMed
    1. Rufai SB, Kumar P, Singh A, Prajapati S, Balooni V, Singh S. 2014. Comparison of Xpert MTB/RIF with line probe assay for detection of rifampin-monoresistant Mycobacterium tuberculosis. J. Clin. Microbiol. 52:1846–1852. 10.1128/JCM.03005-13. - DOI - PMC - PubMed
    1. Kumar P, Balooni V, Sharma BK, Kapil V, Sachdeva KS, Singh S. 2014. High degree of multi-drug resistance and hetero-resistance in pulmonary TB patients from Punjab state of India. Tuberculosis 94:73–80. 10.1016/j.tube.2013.10.001. - DOI - PubMed
    1. Steingart KR, Schiller I, Horne DJ, Pai M, Boehme CC, Dendukuri N. 2014. Xpert MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst. Rev. 1:CD009593. 10.1002/14651858.CD009593.pub3. - DOI - PMC - PubMed
    1. World Health Organization. 2008. Policy statement. Molecular line probe assays for rapid screening of patients at risk of multidrug-resistant tuberculosis (MDR-TB). World Health Organization, Geneva, Switzerland: http://www.who.int/tb/features_archive/policy_statement.pdf Accessed 18 June 2014.

MeSH terms

LinkOut - more resources